Pressure BioSciences, Inc. (PBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 13, 2025, 12:44 PM EDT
Paramount Global Market Cap
Pressure BioSciences has a market cap or net worth of $4.30 thousand as of August 13, 2025. Its market cap has decreased by -99.96% in one year.
Market Cap
4.30K
Enterprise Value
29.18M
Revenue
1.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 31, 1996, Pressure BioSciences's market cap has decreased from 20.85M to 4.30K, a decrease of -99.98%. That is a compound annual growth rate of -25.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 4.30K | -97.00% |
| Dec 31, 2024 | 143.39K | -98.15% |
| Dec 29, 2023 | 7.77M | -51.10% |
| Dec 30, 2022 | 15.89M | -13.44% |
| Dec 31, 2021 | 18.35M | 120.88% |
| Dec 31, 2020 | 8.31M | 177.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |